Synopsys, Inc. (SNPS)

Stalwart

FairStock Score: 30/100 — RISKY

Key Financials

Current Price$502.42
Market Cap$82.9B
P/E Ratio114.97
ROE3.82%
Dividend Yield0%
SectorTechnology

Strengths

Concerns

AI Analysis

Synopsys operates in a strategically important niche—design automation and IP for semiconductors—where switching costs are high and customer lock-in is substantial. This creates a genuine competitive moat. However, I must be frank: at $432.65 with a Graham Number of $34.94, we're looking at a negative margin of safety of -1138%. This is not a value investor's territory. The business generates $3.1B in free cash flow, which is respectable, but the FCF yield of 1.0% is anemic for a $82.9B market cap. More troubling is the financial picture: ROE of 5.54% and ROCE of 2.04% indicate the company struggles to deploy capital efficiently despite its market position. The latest quarter showed a net margin of just 2.70% on $2.4B revenue, suggesting operational leverage isn't materializing. The valuation metrics are punishing. An EV/EBITDA of 132.31x is astronomical. A P/E of 64.57x demands perfection. The Piotroski F-Score of 6/9 is mediocre—not failing, but not robust either. While semiconductor design tools will likely remain essential infrastructure, I see no margin of safety here. The company has priced in decades of flawless execution. There's a narrative of AI-driven chip design demand sustaining growth, but narratives don't build margins of safety. Until valuation contracts meaningfully or earnings growth accelerates dramatically, I'd be a seller at these levels, not a buyer. Synopsys is a quality business at a speculative price.

Bull Case

As AI accelerates chip design complexity and semiconductor demand surges, Synopsys's essential tools and IP become even more critical infrastructure. The company's high switching costs and customer lock-in could justify premium pricing if they can expand margins through operational leverage and pricing power.

Bear Case

If semiconductor growth disappoints or customers develop alternative tools, Synopsys faces margin compression with little pricing flexibility. At these valuations, any deviation from perfect execution creates significant downside risk for shareholders.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer